The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Tuberculosis Diagnostics Market Expected To Scale Between 2026 And 2030?
The tuberculosis diagnostics market has experienced robust growth in recent years. This market is expected to expand from $2.34 billion in 2025 to $2.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.9%. The growth witnessed in the past period can be attributed to the global tuberculosis disease burden, the expansion of public health screening programs, the widespread availability of smear microscopy infrastructure, international funding designated for TB control, and the increased adoption of culture-based diagnostics.
The tuberculosis diagnostics market is anticipated to experience significant expansion in the coming years. This market is projected to reach $3.37 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. Factors contributing to this growth over the forecast period include an increasing need for prompt and precise TB diagnosis, heightened emphasis on identifying drug-resistant TB, the spread of decentralized diagnostic testing facilities, rising capital into molecular diagnostics, and the incorporation of AI-powered diagnostic instruments. Key trends anticipated during this period encompass the greater uptake of molecular TB testing approaches, increased utilization of swift diagnostic platforms, broader incorporation of drug resistance identification, the proliferation of point-of-care TB testing, and a stronger emphasis on highly sensitive diagnostic solutions.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report
What Factors Are Contributing To The Growth Of The Tuberculosis Diagnostics Market?
The increasing occurrence of tuberculosis is propelling the demand for the tuberculosis diagnostics market moving ahead. Tuberculosis (TB), a communicable bacterial ailment mainly affecting the lungs, necessitates prompt detection to avert severe health issues and spread. This increase in TB cases stems from the growing prevalence of HIV/AIDS, which significantly weakens the immune system, leaving individuals highly prone to developing active tuberculosis. Consequently, the escalating incidence of tuberculosis bolsters the tuberculosis diagnostics sector by increasing the need for quick, precise, and point-of-care diagnostic solutions, facilitating early treatment and improved disease management. For instance, in October 2025, the UK Health Security Agency, England’s governmental body for health security, reported a 13.6 percent rise in Tuberculosis levels in England in 2024 compared to 2023, with 5,490 notifications recorded in 2024 against 4,831 in 2023. Thus, the escalating incidence of tuberculosis is fueling the expansion of the tuberculosis diagnostics market.
How Is The Tuberculosis Diagnostics Market Organized By Segment Classification?
The tuberculosis diagnostics market covered in this report is segmented –
1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities
Subsegments:
1) By Radiographic Tests: Chest X-rays, CT Scans
2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays
5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
6) By Blood Or Serology Test: Serological Tests for Antibodies
7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures
9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques
What Trends Are Shaping The Future Of The Tuberculosis Diagnostics Market?
Leading companies operating within the tuberculosis diagnostics market are prioritizing product innovations and the development of new solutions, such as tuberculosis diagnostic tests, to enhance their market standing. Tuberculosis diagnostic tests refer to medical assessments and laboratory methodologies utilized to ascertain whether an individual is infected with Mycobacterium tuberculosis, the bacterium responsible for TB. These tests are instrumental in identifying active TB disease, latent TB infection, and drug-resistant strains, thereby enabling the prompt initiation of appropriate treatment. For example, in February 2023, Redcliffe Labs, an India-based technology-empowered diagnostics service provider, introduced the BD MAX MDR TB (Tuberculosis) test, a diagnostic tool designed for clinicians to rapidly screen for tuberculosis and multidrug resistance as a first-line test, executed on the BD MAX molecular diagnostic system. Clinicians leverage this test to simultaneously detect the bacteria causing TB and ascertain if the bacteria possess mutations linked to resistance against two significant first-line drugs, Isoniazid (INH) and Rifampicin (RIF).
Who Are The Industry Participants Involved In The Tuberculosis Diagnostics Market?
Major companies operating in the tuberculosis diagnostics market are Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt.Ltd, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Bio Certica, BixBio
Get The Full Tuberculosis Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report
Which Geographic Region Dominates The Tuberculosis Diagnostics Market?
Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2025. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Tuberculosis Diagnostics Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report
Browse Through More Reports Similar to the Global Tuberculosis Diagnostics Market 2026, By The Business Research Company
Infectious Disease Diagnostics Testing Market Report 2026
Medical And Diagnostic Laboratory Services Market Report 2026
Clinical Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model